Janssen

J&J touts first-in-human data for HIV vaccine
Drug Delivery Business News
Tue, 07/25/17 - 12:00 am
JNJ
HIV
vaccines
Janssen
Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials
Forbes
Thu, 07/13/17 - 09:10 am
New Hampshire
Actavis
Endo Pharmaceuticals
Janssen
Purdue Pharma
Teva Pharmaceutical
Janssen gets EU nod for continuous manufacturing
BioPharma Dive
Fri, 06/30/17 - 09:45 am
Janssen
Europe
drug manufacturing
Prezista
HIV
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
CNBC
Wed, 05/31/17 - 10:54 pm
Ohio
opioid crisis
opioids
opioid abuse
JNJ
Janssen
Teva Pharmaceutical
Purdue Pharma
Allergan
Endo Health Solutions
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug
Bloomberg
Thu, 05/18/17 - 10:01 pm
FDA
JNJ
Risperdal
Janssen
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
Tue, 05/16/17 - 10:48 pm
FDA
Janssen
type 2 diabetes
warnings
Invokana
Invokamet
J&J looks for the inside story with new online psoriasis campaign
Fierce Pharma
Tue, 03/28/17 - 10:54 am
JNJ
psoriasis
Janssen
drug marketing
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Fierce Biotech
Tue, 02/7/17 - 10:34 am
Renova Therapeutics
gene therapy
heart failure
Janssen
stresscopin
FDA to withdraw approval of Lannett's generic ADHD drug
Bizjournals.com
Thu, 10/20/16 - 09:30 am
FDA
Lannett
generics
ADHD
Concerta
JNJ
Janssen
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
Mon, 09/26/16 - 09:58 am
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
Wed, 09/7/16 - 09:37 am
GSK
Gilead Sciences
HIV
Tivicay
Edurant
Janssen
ViiV
GSK enters $230 million licensing deal with Janssen
BioPharma Dive
Thu, 07/28/16 - 01:46 pm
GSK
Janssen
asthma
J&J's Janssen hit with $70 mln verdict in Risperdal trial
Yahoo/Reuters
Sat, 07/2/16 - 12:41 pm
JNJ
Janssen
Risperdal
antipsychotics
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
BioPharma Dive
Tue, 06/14/16 - 07:27 pm
FDA
diabetes
Janssen
JNJ
AstraZeneca
Farxiga
Invokana
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Fierce Pharma
Mon, 06/13/16 - 07:10 pm
JNJ
Invokana
type 1 diabetes
Janssen
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Tue, 05/24/16 - 11:42 pm
Janssen
Multiple Myeloma
Europe
JNJ
Darazalex
MacroGenics scores drug licensing deal worth up to $740 million
Bizjournals.com
Fri, 05/20/16 - 10:23 am
Macrogenics
Janssen
MGD015
cancer immunotherapy
Updated survival data added to Imbruvica's label
BioPharma Dive
Wed, 05/11/16 - 06:41 pm
Imbruvica
CLL
Janssen
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
ViiV Healthcare
Pfizer
GSK
Shionogi
AbbVie
Lundbeck
Janssen
Novo Nordisk
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
BioPharma Dive
Mon, 03/7/16 - 10:00 pm
Novartis
Cosentyx
Janssen
Stelara
psoriasis

Pages